This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $199,744.50, is for a standard service agreement for Cepheid's GeneXpert system. The contract has an ultimate completion date of December 10, 2026. Cepheid is the prime contractor and there is no set-aside designation for this award. Cepheid has previously received numerous federal contract and grant awards from agencies...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $123,607.98, is for a service agreement (GX16A1Y) with an ultimate completion date of April 12, 2027. Cepheid, which is registered in the System for Award Management (SAM.gov), will provide the DHA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $279,558.00 contract is for a GeneXpert service agreement to provide equipment, reagents, test kits, and maintenance services for molecular diagnostic testing capabilities, including for detecting infectious diseases such as COVID-19, influenza, and others. Cepheid holds several significant federal contract Indefinite Delivery Vehicles (IDVs)...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a CEPHEID GENEXPERT LABORATORY SYSTEMS SERVICE AGREEMENT AND PREVENTIVE MAINTENANCE contract. The contract has a ceiling value of $78,830.00 and an ultimate completion date of January 31, 2029. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for...
The U.S. Department of Defense's Defense Health Agency has awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for services related to Cepheid's GeneXpert DX Systems in the Department of Pathology. The contract, valued at $326,745.25, has an ultimate completion date of September 10, 2025. Cepheid, the prime contractor, is not designated as a set-aside. The company has a history of providing diagnostic testing equipment,...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide annual maintenance services for GeneXpert diagnostic systems. The $161,500.00 contract has a completion date of August 28, 2027 and does not have a set-aside designation. Cepheid has received numerous other federal contract awards and grants to supply the Department of Veterans Affairs, the Defense Logistics Agency, and the...
This is a $494,875.00 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for CEPHEID GENX SERVICES, with an ultimate completion date of April 9, 2028. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. Under this contract,...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for $13,000.50 to provide maintenance service for GeneXpert diagnostic equipment. The contract has an ultimate completion date of April 17, 2025. Cepheid is a leading provider of diagnostic equipment, reagents, and support services to federal agencies, including the Department of Veterans Affairs (VA) and Department of Health and Human...
The Defense Health Agency has awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert IV Service Agreement plus four option years. The contract, valued at $36,197.21, will provide GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs for the agency. Cepheid is the prime contractor and original equipment manufacturer, and the contract does not have a...
The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the procurement of FY 22 new Cepheid GeneXpert Analyzers. The contract has a ceiling value of $79,000.00 and an ultimate completion date of September 22, 2027. The contract does not have a set-aside designation. Cepheid has received numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and...